| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.003 |